Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3682756015 | Product containing precisely rivastigmine (as rivastigmine tartrate) 4.5 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3682757012 | Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule | Is a | Rivastigmine only product in oral dose form | true | Inferred relationship | Some | ||
| Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule | Plays role | Antidementia therapeutic role | true | Inferred relationship | Some | ||
| Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule | Is a | Rivastigmine-containing product | false | Inferred relationship | Some | ||
| Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule | Has active ingredient | Central nervous system agent | false | Inferred relationship | Some | ||
| Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule | Has active ingredient | Rivastigmine | false | Inferred relationship | Some | ||
| Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Some | ||
| Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule | Has active ingredient | Rivastigmine hydrogen tartrate | false | Inferred relationship | Some | ||
| Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule | Is a | Rivastigmine-containing product in oral dose form | false | Inferred relationship | Some | ||
| Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule | Has manufactured dose form | Conventional release oral capsule | true | Inferred relationship | Some | ||
| Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule | Has active ingredient | Rivastigmine hydrogen tartrate | false | Inferred relationship | Some | 1 | |
| Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule | Has BoSS | Rivastigmine | true | Inferred relationship | Some | 1 | |
| Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule | Has presentation strength numerator value | 4.5 | false | Inferred relationship | Some | 1 | |
| Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Some | 1 | |
| Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule | Has active ingredient | Rivastigmine | false | Inferred relationship | Some | ||
| Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule | Has precise active ingredient | Rivastigmine hydrogen tartrate | true | Inferred relationship | Some | 1 | |
| Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule | Has unit of presentation | Capsule | true | Inferred relationship | Some | ||
| Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule | Count of base of active ingredient | 1 | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR